dc.creator | Cengiz, Mahir | |
dc.creator | Borku Uysal, Betul | |
dc.creator | Ikitimur, Hande | |
dc.creator | Ozcan, Erkan | |
dc.creator | Sami Islamoglu, Mehmet | |
dc.creator | Aktepe, Emre | |
dc.creator | Yavuzer, Hakan | |
dc.creator | Yavuzer, Serap | |
dc.date.accessioned | 2020-09-22T15:48:47Z | |
dc.date.accessioned | 2022-09-23T18:37:22Z | |
dc.date.available | 2020-09-22T15:48:47Z | |
dc.date.available | 2022-09-23T18:37:22Z | |
dc.date.created | 2020-09-22T15:48:47Z | |
dc.identifier | 2352-9393 | |
dc.identifier | https://doi.org/10.1016/j.yclnex.2020.07.003 | |
dc.identifier | http://hdl.handle.net/20.500.12010/13564 | |
dc.identifier | https://doi.org/10.1016/j.yclnex.2020.07.003 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/3504327 | |
dc.description.abstract | Objectives: The aim of this study is to investigate the effect of oral
L-Glutamine supplementation on hospitalization time, need for
intensive care unit and Coronavirus Disease-19 (Covid-19)
mortality.
Methods: The study included 30 Covid-19 patients using L-Glutamine and 30 Covid-19 patients who did not use L-Glutamine with
similar age, gender and clinical status. Diagnostic tests, laboratory
examinations, clinical findings and computed thorax tomography
imaging of the patients were evaluated.
Results: Hospitalization time was 10.4 ± 1.9 days in Covid-19
without L-Glutamine group and 8.9 ± 1.8 days in Covid-19 with LGlutamine group (p ¼ 0.005). In Covid-19 without the L-Glutamine
group, four patients require the ICU though no one in the other
group required that (p ¼ 0.038). Only one mortality was observed
in Covid-19 without the L-Glutamine group (p ¼ 0.999).
Conclusions: Nutritional supplements such as L-Glutamine boost
immune system especially by inhibition of inflammatory responses. Our results suggest adding enteral L-glutamine to the
normal nutrition in the early period of Covid-19 infection may lead
to a shortened hospital stay and lead to less need for ICU. Largerscale studies are needed to evaluate the effect of adding enteral LGlutamine to the currently used treatments in the infectious diseases especially like Covid-19. | |
dc.language | eng | |
dc.publisher | Clinical Nutrition Experimental | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.rights | Abierto (Texto Completo) | |
dc.source | reponame:Expeditio Repositorio Institucional UJTL | |
dc.source | instname:Universidad de Bogotá Jorge Tadeo Lozano | |
dc.subject | Covid-19 | |
dc.subject | SARS Cov-2 | |
dc.subject | Pneumonia | |
dc.subject | L-Glutamine | |
dc.subject | Nutrition | |
dc.title | Effect of oral L-Glutamine supplementation on Covid-19 treatment | |